IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

MARFELLA, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.782
EU - Europa 2.161
AS - Asia 958
SA - Sud America 272
AF - Africa 132
Continente sconosciuto - Info sul continente non disponibili 41
OC - Oceania 1
Totale 6.347
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.679
RU - Federazione Russa 1.526
SG - Singapore 363
CN - Cina 205
BR - Brasile 191
IT - Italia 155
DE - Germania 132
FR - Francia 114
VN - Vietnam 107
CI - Costa d'Avorio 96
HK - Hong Kong 72
BD - Bangladesh 62
GB - Regno Unito 57
CA - Canada 53
IN - India 31
MX - Messico 30
PL - Polonia 27
IE - Irlanda 25
AR - Argentina 22
FI - Finlandia 20
ES - Italia 19
NL - Olanda 19
ID - Indonesia 18
IQ - Iraq 17
ZA - Sudafrica 17
CO - Colombia 14
JP - Giappone 14
AT - Austria 13
EC - Ecuador 12
UA - Ucraina 12
CZ - Repubblica Ceca 10
LT - Lituania 9
CL - Cile 8
VE - Venezuela 8
JM - Giamaica 7
TR - Turchia 7
PH - Filippine 6
PK - Pakistan 6
RO - Romania 6
SA - Arabia Saudita 6
SE - Svezia 6
TH - Thailandia 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
JO - Giordania 5
MA - Marocco 5
MY - Malesia 5
HN - Honduras 4
PE - Perù 4
UZ - Uzbekistan 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
PT - Portogallo 3
TW - Taiwan 3
BE - Belgio 2
CR - Costa Rica 2
EG - Egitto 2
IL - Israele 2
NP - Nepal 2
PY - Paraguay 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
SC - Seychelles 1
TM - Turkmenistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 6.306
Salva come PNG Salva come JPEG
Città #
Dallas 1.010
Moscow 520
San Jose 487
Ashburn 207
Singapore 190
Abidjan 96
Frankfurt am Main 91
Beijing 85
Council Bluffs 81
Hong Kong 71
The Dalles 70
New York 60
Lauterbourg 55
Los Angeles 55
Ho Chi Minh City 45
Santa Clara 38
Phoenix 31
Boardman 27
Dublin 25
Orem 24
Warsaw 24
Hanoi 23
Denver 20
São Paulo 20
Chennai 18
Milan 18
Brooklyn 16
Montreal 16
Munich 16
London 15
Toronto 15
Amsterdam 13
Chicago 13
Poplar 13
Tokyo 13
Naples 11
San Francisco 11
Atlanta 10
Campobasso 10
Helsinki 10
Houston 10
Jacksonville 10
Manchester 10
Mexico City 10
Nuremberg 10
Boston 9
Columbus 9
Figino 9
Brno 8
Johannesburg 8
Querétaro 8
Terzigno 8
Buffalo 7
Chandler 7
Falkenstein 7
Hillsboro 7
Mumbai 7
Rome 7
Roubaix 7
Baghdad 6
Curitiba 6
Córdoba 6
Kingston 6
Montevideo 6
Rio de Janeiro 6
Acerra 5
Ankara 5
Bexley 5
Charlotte 5
Lappeenranta 5
Memphis 5
Santiago 5
Stockholm 5
Turku 5
Vancouver 5
Vienna 5
Wilmington 5
Amman 4
Assago 4
Bangkok 4
Da Nang 4
Erbil 4
Guarulhos 4
Haiphong 4
Jakarta 4
Limburg an der Lahn 4
Ottawa 4
Quito 4
Tashkent 4
Baie-D'Urfé 3
Brasília 3
Caracas 3
Casablanca 3
Dammam 3
Guayaquil 3
Lahore 3
Las Vegas 3
Lima 3
Medellín 3
Miami 3
Totale 3.908
Salva come PNG Salva come JPEG
Nome #
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 622
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 160
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 153
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 143
ELectrophysiological mechanisms underlying the Inhibitory CArdiac syncope without asystolic significant pause: Therapeutic and prognostic implications. The ELICA randomized trial 143
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study 140
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 135
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 130
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 129
Advances in Nanomedicine for Precision Insulin Delivery 128
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 125
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 123
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 122
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 120
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 119
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 118
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 116
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 115
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 114
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 111
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 109
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 107
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 106
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 105
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 104
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 102
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 101
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 92
Cardiovascular benefits from gliflozins: Effects on endothelial function 90
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 88
Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity 85
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 85
Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients 85
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 78
MicroRNAs modulation and clinical outcomes at 1 year of follow-up in obese patients with pre-diabetes treated with metformin vs. placebo 77
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 76
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 75
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 74
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 73
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 72
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 71
Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19 71
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 70
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 69
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 68
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up 68
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 67
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 67
Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes 66
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 66
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 66
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 66
Role of subcutaneous abdominal fat on cardiac function and proinflammatory cytokines in premenopausal obese women 65
Metformin: An old drug against old age and associated morbidities 63
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 61
Patients with adrenal insufficiency have cardiovascular features associated with hypovolemia 57
Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review 57
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 56
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 54
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 54
Cardiovascular Therapeutics at the Crossroads: Pharmacological, Genetic, and Digital Frontiers 53
Metformin Lactic Acidosis: should we still be afraid? 52
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study 42
Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging Paradigm 29
Impact of achieving glycated hemoglobin targets on cardiovascular events/mortality: Post-hoc analysis of the nephropathy in diabetes type 2 trial 19
Vericiguat for endothelial dysfunction and CRT response in non-responders: the VERCET prospective observational study 17
Micro- and Nanoplastics as Disruptors of Digestive and Hepatopancreatic Homeostasis: Insights into the Plastic-Gut-Liver Axis 3
Totale 6.347
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.666
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228 0 0 0 0 0 0 2 1 1 2 0 2
2022/202347 5 1 0 3 2 2 0 3 25 1 5 0
2023/202493 3 2 2 2 4 15 3 7 1 5 5 44
2024/2025862 130 48 95 11 139 13 22 49 88 23 107 137
2025/20264.883 157 396 816 329 961 887 412 137 212 371 167 38
2026/2027425 153 143 129 0 0 0 0 0 0 0 0 0
Totale 6.347